PDE9 inhibition promotes proliferation of neural stem cells via cGMP-PKG pathway following oxygen-glucose deprivation/reoxygenation injury in vitro
Authors:
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 133, 104630
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 29 references indexed in Scilit:
- Sonic Hedgehog Signaling Pathway Mediates Cerebrolysin-Improved Neurological Function After StrokeStroke, 2013
- New synaptic and molecular targets for neuroprotection in Parkinson's diseaseMovement Disorders, 2012
- Neural stem cell transplantation in central nervous system disordersCurrent Opinion in Neurology, 2012
- The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodentsNeuropharmacology, 2011
- Sleep deprivation prevents stimulation-induced increases of levels of P-CREB and BDNF: Protection by caffeineMolecular and Cellular Neuroscience, 2011
- A Protocol for Isolation and Enriched Monolayer Cultivation of Neural Precursor Cells from Mouse Dentate GyrusFrontiers in Neuroscience, 2011
- Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disordersJournal of Neurochemistry, 2009
- The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodentsNeuropharmacology, 2008
- Selective phosphodiesterase inhibitors: a promising target for cognition enhancementPsychopharmacology, 2008
- Expression of the cGMP‐specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brainsEuropean Journal of Neuroscience, 2007